A cluster included patients whose PKR location in the cytoplasm of the tumour cells corresponded with a positive response to the treatment, and although the levels of expression of PKR and nc886 analysed were variable between samples, they were necessary to establish statistically significant clusters. The gene discussed is EIF2AK2; the disease is neoplasm.